|

Alisertib Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: MLN8237, PB-8237

Birmingham, Alabama1 trial

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Alabama Oncology

Phase 2

Daphne, Alabama1 trial

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

Southern Cancer Center

Phase 2

San Francisco, California1 trial

Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

University of California, San Francisco

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.